메뉴 건너뛰기




Volumn 117, Issue 4, 2011, Pages

Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis

Author keywords

Chronic kidney disease; Erythropoiesis stimulating agent; Erythropoietin; Hemodialysis; Hyporesponsiveness; Renal anemia; Vitamin D

Indexed keywords

ALBUMIN; CALCIFEDIOL; FERRIC GLUCONATE; HEMOGLOBIN; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; SERUM ALBUMIN;

EID: 78149311906     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321521     Document Type: Article
Times cited : (69)

References (49)
  • 1
    • 0035134102 scopus 로고    scopus 로고
    • Relationship between hematocrit and renal function in men and women
    • DOI 10.1046/j.1523-1755.2001.059002725.x
    • Hsu CY, Bates DW, Kuperman GJ, Curhan GC: Relationship between hematocrit and renal function in men and women. Kidney Int 2001;59:725-731. (Pubitemid 32157938)
    • (2001) Kidney International , vol.59 , Issue.2 , pp. 725-731
    • Chi-Yuan, H.1    Bates, D.W.2    Kuperman, G.J.3    Curhan, G.C.4
  • 3
    • 33645474065 scopus 로고    scopus 로고
    • Association between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
    • Regidor DL, Kopple JD, Kovesdy CP, et al: Association between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006;17:1181-1191.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1181-1191
    • Regidor, D.L.1    Kopple, J.D.2    Kovesdy, C.P.3
  • 7
    • 34547673679 scopus 로고    scopus 로고
    • Maintaining control over haemoglobin levels: Optimizing the management of anaemia in chronic kidney disease
    • Bárány P, Müller HJ: Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease. Nephrol Dial Transplant 2007;22(suppl 4):iv10-iv18.
    • (2007) Nephrol Dial Transplant , vol.22 , Issue.SUPPL. 4
    • Bárány, P.1    Müller, H.J.2
  • 9
    • 34547414592 scopus 로고    scopus 로고
    • Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations
    • Ebben JP, Gilbertson DT, Foley RN, Collins AJ: Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 2006;1:1205-1210.
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 1205-1210
    • Ebben, J.P.1    Gilbertson, D.T.2    Foley, R.N.3    Collins, A.J.4
  • 10
    • 60149091852 scopus 로고    scopus 로고
    • Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients
    • Kalantar-Zadeh K, Lee GH, Miller JE, et al: Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 2009;53:823-834.
    • (2009) Am J Kidney Dis , vol.53 , pp. 823-834
    • Kalantar-Zadeh, K.1    Lee, G.H.2    Miller, J.E.3
  • 11
    • 0036174760 scopus 로고    scopus 로고
    • Clinical factors influencing sensitivity and response to epoetin
    • Richardson D: Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant 2002;17(suppl 1):53-59.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 1 , pp. 53-59
    • Richardson, D.1
  • 12
    • 27744477210 scopus 로고    scopus 로고
    • Inflammation and resistance to erythropoiesis-stimulating agents - What do we know and what needs to be clarified?
    • Smrzova J, Balla J, Bárány P: Inflammation and resistance to erythropoiesis-stimulating agents - what do we know and what needs to be clarified? Nephrol Dial Transplant 2005;20(suppl 8):viii2-viii7.
    • (2005) Nephrol Dial Transplant , vol.20 , Issue.SUPPL. 8
    • Smrzova, J.1    Balla, J.2    Bárány, P.3
  • 13
    • 0029038221 scopus 로고
    • Poor response to erythropoietin: Practical guidelines on investigation and management
    • Macdougall IC: Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant 1995;10:607-614.
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 607-614
    • Macdougall, I.C.1
  • 14
    • 37349055203 scopus 로고    scopus 로고
    • Mechanisms of Disease: Erythropoietin resistance in patients with both heart and kidney failure
    • DOI 10.1038/ncpneph0655, PII NCPNEPH0655
    • Van der Putten K, Braam B, Jie KE, Gaillard CA: Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol 2008;4:47-57. (Pubitemid 350308210)
    • (2008) Nature Clinical Practice Nephrology , vol.4 , Issue.1 , pp. 47-57
    • Van Der, P.K.1    Braam, B.2    Jie, K.E.3    Gaillard, C.A.J.M.4
  • 15
    • 34447542038 scopus 로고    scopus 로고
    • Erythropoiesis-stimulating agent hyporresponsiveness
    • Johnson DW, Pollock CA, Macdougall IC: Erythropoiesis-stimulating agent hyporresponsiveness. Nephrology 2007;12:321-330.
    • (2007) Nephrology , vol.12 , pp. 321-330
    • Johnson, D.W.1    Pollock, C.A.2    Macdougall, I.C.3
  • 16
    • 33847649904 scopus 로고    scopus 로고
    • Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients
    • DOI 10.1093/ndt/gfl716
    • Rossert J, Gassmann-Mayer C, Frei D, McClellan W: Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients. Nephrol Dial Transplant 2007;22:794-800. (Pubitemid 46351687)
    • (2007) Nephrology Dialysis Transplantation , vol.22 , Issue.3 , pp. 794-800
    • Rossert, J.1    Gassmann-Mayer, C.2    Frei, D.3    McClellan, W.4
  • 17
    • 0035168242 scopus 로고    scopus 로고
    • Hyporesponsiveness to recombinant human erythropoietin
    • Drüeke T: Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001;16(suppl 7):25-28.
    • (2001) Nephrol Dial Transplant , vol.16 , Issue.SUPPL. 7 , pp. 25-28
    • Drüeke, T.1
  • 19
    • 33645292037 scopus 로고    scopus 로고
    • Managing erythropoietin hyporesponsiveness
    • DOI 10.1111/j.1525-139X.2006.00141.x
    • Kwack C, Balakrishnan VS: Managing erythropoietin hyporesponsiveness. Semin Dial 2006;19:146-151. (Pubitemid 43468648)
    • (2006) Seminars in Dialysis , vol.19 , Issue.2 , pp. 146-151
    • Kwack, C.1    Balakrishnan, V.S.2
  • 21
    • 11144343632 scopus 로고    scopus 로고
    • Intractable anemia among hemodialysis patients: A sign of suboptimal management or a marker of disease?
    • Kausz AT, Solid C, Pereira BJG, Collins AJ, St. Peter W: Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease? Am J Kidney Dis 2005;45:136-147.
    • (2005) Am J Kidney Dis , vol.45 , pp. 136-147
    • Kausz, A.T.1    Solid, C.2    Pereira, B.J.G.3    Collins, A.J.4    St Peter, W.5
  • 23
    • 0031780146 scopus 로고    scopus 로고
    • The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - The experience of the Lombardy Dialysis Registry
    • DOI 10.1093/ndt/13.7.1642
    • Locatelli F, Conte F, Marcelli D: The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity-the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant 1998;13:1642-1644. (Pubitemid 28306788)
    • (1998) Nephrology Dialysis Transplantation , vol.13 , Issue.7 , pp. 1642-1644
    • Locatelli, F.1    Conte, F.2    Marcelli, D.3
  • 24
    • 49149113180 scopus 로고    scopus 로고
    • Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
    • Kilpatrick RD, Critchlow CW, Fishbane S, et al: Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clin J Am Soc Nephrol 2008;3:1077-1083.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1077-1083
    • Kilpatrick, R.D.1    Critchlow, C.W.2    Fishbane, S.3
  • 25
    • 0038059244 scopus 로고    scopus 로고
    • Vitamin D in preventive medicine: Are we ignoring the evidence?
    • Zittermann A: Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552-572.
    • (2003) Br J Nutr , vol.89 , pp. 552-572
    • Zittermann, A.1
  • 26
    • 23844489806 scopus 로고    scopus 로고
    • Vitamin D for health and in chronic kidney disease
    • Holick MF: Vitamin D for health and in chronic kidney disease. Semin Dial 2005;18:266-275.
    • (2005) Semin Dial , vol.18 , pp. 266-275
    • Holick, M.F.1
  • 28
    • 58749107512 scopus 로고    scopus 로고
    • Case 3-2009: A 9-month-old boy with seizures
    • Holick MF, Lim R, Dighe AS: Case 3-2009: a 9-month-old boy with seizures. N Engl J Med 2009;360:398-407.
    • (2009) N Engl J Med , vol.360 , pp. 398-407
    • Holick, M.F.1    Lim, R.2    Dighe, A.S.3
  • 29
    • 53749085098 scopus 로고    scopus 로고
    • Vitamin D in health and disease
    • Heaney RP: Vitamin D in health and disease. Clin J Am Soc Nephrol 2008;3:1535-1541.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1535-1541
    • Heaney, R.P.1
  • 32
    • 0036789059 scopus 로고    scopus 로고
    • The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients
    • Ertürk S, Kutlay S, Karabulut HG, et al: The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Am J Kidney Dis 2002;40:816-823.
    • (2002) Am J Kidney Dis , vol.40 , pp. 816-823
    • Ertürk, S.1    Kutlay, S.2    Karabulut, H.G.3
  • 33
    • 33846593857 scopus 로고    scopus 로고
    • Possible Influence of Vitamin D Receptor Gene Polymorphisms on Recombinant Human Erythropoietin Requirements in Dialysis Patients
    • DOI 10.1016/j.transproceed.2006.10.214, PII S0041134506014771
    • Sezer S, Tutal L, Bilgic A, Ozdemir FN, Haberal M: Possible influence of vitamin D receptor gene polymorphisms on recombinant human erythropoietin requirements in dialysis patients. Transpl Proc 2007;39:40-44. (Pubitemid 46175972)
    • (2007) Transplantation Proceedings , vol.39 , Issue.1 , pp. 40-44
    • Sezer, S.1    Tutal, E.2    Bilgic, A.3    Ozdemir, F.N.4    Haberal, M.5
  • 35
    • 33644533243 scopus 로고    scopus 로고
    • Elderly patients on chronic hemodialysis with hyperparathyroidism: Increase of hemoglobin level after intravenous calcitriol
    • Neves PL, Trivino J, Casaubon F, et al: Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol. Int Urol Nephrol 2006;38:175-177.
    • (2006) Int Urol Nephrol , vol.38 , pp. 175-177
    • Neves, P.L.1    Trivino, J.2    Casaubon, F.3
  • 36
    • 0031983977 scopus 로고    scopus 로고
    • Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients
    • DOI 10.1159/000044877
    • Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perey-Garcia R, Valderrabano F: Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 1998;78:23-27. (Pubitemid 28014455)
    • (1998) Nephron , vol.78 , Issue.1 , pp. 23-27
    • Goicoechea, M.1    Vazquez, M.I.2    Ruiz, M.A.3    Gomez-Campdera, F.4    Perez-Garcia, R.5    Valderrabano, F.6
  • 37
    • 59749095297 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease
    • Kendrick J, Targer G, Smits G, Chonchol M: 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol 2009;30:64-72.
    • (2009) Am J Nephrol , vol.30 , pp. 64-72
    • Kendrick, J.1    Targer, G.2    Smits, G.3    Chonchol, M.4
  • 38
    • 77950520947 scopus 로고    scopus 로고
    • Vitamin D deficiency and anemia in early chronic kidney disease
    • Patel NM, Gutiérrez OM, Andress DL, et al: Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 2010;77:715-720.
    • (2010) Kidney Int , vol.77 , pp. 715-720
    • Patel, N.M.1    Gutiérrez, O.M.2    Andress, D.L.3
  • 42
    • 52149102501 scopus 로고    scopus 로고
    • Vitamin D and sunlight: Strategies for cancer prevention and other health benefits
    • Holick MF: Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol 2008;3:1548-1554.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1548-1554
    • Holick, M.F.1
  • 43
    • 44449113816 scopus 로고    scopus 로고
    • Vitamin D receptor activation and survival in chronic kidney disease
    • DOI 10.1038/ki.2008.35, PII KI200835
    • Kovesdy CP, Kalantar-Zadeh: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 2008;73:1355-1363. (Pubitemid 351770491)
    • (2008) Kidney International , vol.73 , Issue.12 , pp. 1355-1363
    • Kovesdy, C.P.1    Kalantar-Zadeh, K.2
  • 44
    • 0031012999 scopus 로고    scopus 로고
    • How important is vitamin D deficiency in uraemia?
    • Cunningham J, Makin H: How important is vitamin D deficiency in uraemia? Nephrol Dial Transplant 1997;12:16-18.
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 16-18
    • Cunningham, J.1    Makin, H.2
  • 45
    • 0036842101 scopus 로고    scopus 로고
    • Vitamin D deficiency: A neglected aspect of disturbed calcium metabolism in renal failure
    • Cannata-Andía JB, Gómez Alonso C: Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 2002;17:1875-1878.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1875-1878
    • Cannata-Andía, J.B.1    Gómez Alonso, C.2
  • 48
    • 0031694522 scopus 로고    scopus 로고
    • Prevalence of subclinical vitamin D deficiency in different European countries
    • Scharla SH: Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int 1998;8(suppl 2):S7-S12.
    • (1998) Osteoporos Int , vol.8 , Issue.SUPPL. 2
    • Scharla, S.H.1
  • 49
    • 0033031374 scopus 로고    scopus 로고
    • Is low plasma 25(OH)-vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    • Ghazali A, Fardellone P, Pruna A, et al: Is low plasma 25(OH)-vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 1999;55:2169-2177.
    • (1999) Kidney Int , vol.55 , pp. 2169-2177
    • Ghazali, A.1    Fardellone, P.2    Pruna, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.